新冠病毒 spike 抗体, 识别omicron, 鼠单抗,抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized ……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with m13 phage.……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with a synthetic peptide corresponding……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with purified, a synthetic……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with m13 bacteriophage.……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with the n-terminus of ……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with a synthetic peptide corresponding ……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with purified……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with purified……
抗体制备:this antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with b cells obtained from a mouse immunized with purified……
重组人vegf165(recombinant human vegf165)是一种重要的生物制剂,属于血管内皮生长因子(vegf)家族的一员。重组人vegf165(重组人血管内皮生长因子165)是由大肠杆菌原核表达系统制备的重组蛋白,是在符合gmp标准要求的洁净间内由原核系统表达、经分离纯化和过滤除菌等步骤制成,分子量约为18.7 kda。